img

Global Estrogen Receptor Modulators Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Estrogen Receptor Modulators Market Research Report 2024

Estrogen receptor modulators are a type of pharmacological agent that blocks the estrogen's function in the tissues by binding to estrogen receptors located at numerous tissues. It is either act as agonists or antagonists in diverse tissues and is widely used in the treatment of breast cancer and post-menopausal osteoporosis.It is of great importance to the healthcare sector
According to Mr Accuracy reports’s new survey, global Estrogen Receptor Modulators market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Estrogen Receptor Modulators market research.
The International Osteoporosis Foundation estimates that 75 million people in Europe, the United States and Japan have osteoporosis. Osteoporosis is characterized by low bone mass and structural deterioration of bone tissue, leading to an increased risk of fractures. SERMs are effective in controlling and preventing osteoporosis, especially in postmenopausal women. With aging population and increasing prevalence of osteoporosis, demand for SERMs as an effective treatment option is expected to increase, thereby driving the global selective estrogen receptor modulators market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Estrogen Receptor Modulators market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


F. Hoffmann-La Roche Ltd
Mylan NV
Teva Pharmaceutical Industries Ltd
Sanofi
Pfizer Inc
GSK plc
Novartis AG
Bayer AG
Lilly
Merck & Co., Inc
Sun Pharmaceutical Industries Ltd
Aurobindo Pharma
Alkem Labs Ltd
Apotex Inc
Kyowa Kirin Co., Ltd
Segment by Type
Breast Cancer
Vaginitis
Osteoporosis
Other

Segment by Application


Breast Cancer
Postmenopausal Osteoporosis
Other

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Estrogen Receptor Modulators report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Estrogen Receptor Modulators Market Overview
1.1 Product Overview and Scope of Estrogen Receptor Modulators
1.2 Estrogen Receptor Modulators Segment by Type
1.2.1 Global Estrogen Receptor Modulators Market Value Comparison by Type (2024-2034)
1.2.2 Breast Cancer
1.2.3 Vaginitis
1.2.4 Osteoporosis
1.2.5 Other
1.3 Estrogen Receptor Modulators Segment by Application
1.3.1 Global Estrogen Receptor Modulators Market Value by Application: (2024-2034)
1.3.2 Breast Cancer
1.3.3 Postmenopausal Osteoporosis
1.3.4 Other
1.4 Global Estrogen Receptor Modulators Market Size Estimates and Forecasts
1.4.1 Global Estrogen Receptor Modulators Revenue 2018-2029
1.4.2 Global Estrogen Receptor Modulators Sales 2018-2029
1.4.3 Global Estrogen Receptor Modulators Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Estrogen Receptor Modulators Market Competition by Manufacturers
2.1 Global Estrogen Receptor Modulators Sales Market Share by Manufacturers (2018-2024)
2.2 Global Estrogen Receptor Modulators Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Estrogen Receptor Modulators Average Price by Manufacturers (2018-2024)
2.4 Global Estrogen Receptor Modulators Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Estrogen Receptor Modulators, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Estrogen Receptor Modulators, Product Type & Application
2.7 Estrogen Receptor Modulators Market Competitive Situation and Trends
2.7.1 Estrogen Receptor Modulators Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Estrogen Receptor Modulators Players Market Share by Revenue
2.7.3 Global Estrogen Receptor Modulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Estrogen Receptor Modulators Retrospective Market Scenario by Region
3.1 Global Estrogen Receptor Modulators Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Estrogen Receptor Modulators Global Estrogen Receptor Modulators Sales by Region: 2018-2029
3.2.1 Global Estrogen Receptor Modulators Sales by Region: 2018-2024
3.2.2 Global Estrogen Receptor Modulators Sales by Region: 2024-2029
3.3 Global Estrogen Receptor Modulators Global Estrogen Receptor Modulators Revenue by Region: 2018-2029
3.3.1 Global Estrogen Receptor Modulators Revenue by Region: 2018-2024
3.3.2 Global Estrogen Receptor Modulators Revenue by Region: 2024-2029
3.4 North America Estrogen Receptor Modulators Market Facts & Figures by Country
3.4.1 North America Estrogen Receptor Modulators Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Estrogen Receptor Modulators Sales by Country (2018-2029)
3.4.3 North America Estrogen Receptor Modulators Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Estrogen Receptor Modulators Market Facts & Figures by Country
3.5.1 Europe Estrogen Receptor Modulators Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Estrogen Receptor Modulators Sales by Country (2018-2029)
3.5.3 Europe Estrogen Receptor Modulators Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Estrogen Receptor Modulators Market Facts & Figures by Country
3.6.1 Asia Pacific Estrogen Receptor Modulators Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Estrogen Receptor Modulators Sales by Country (2018-2029)
3.6.3 Asia Pacific Estrogen Receptor Modulators Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Estrogen Receptor Modulators Market Facts & Figures by Country
3.7.1 Latin America Estrogen Receptor Modulators Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Estrogen Receptor Modulators Sales by Country (2018-2029)
3.7.3 Latin America Estrogen Receptor Modulators Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Estrogen Receptor Modulators Market Facts & Figures by Country
3.8.1 Middle East and Africa Estrogen Receptor Modulators Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Estrogen Receptor Modulators Sales by Country (2018-2029)
3.8.3 Middle East and Africa Estrogen Receptor Modulators Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Estrogen Receptor Modulators Sales by Type (2018-2029)
4.1.1 Global Estrogen Receptor Modulators Sales by Type (2018-2024)
4.1.2 Global Estrogen Receptor Modulators Sales by Type (2024-2029)
4.1.3 Global Estrogen Receptor Modulators Sales Market Share by Type (2018-2029)
4.2 Global Estrogen Receptor Modulators Revenue by Type (2018-2029)
4.2.1 Global Estrogen Receptor Modulators Revenue by Type (2018-2024)
4.2.2 Global Estrogen Receptor Modulators Revenue by Type (2024-2029)
4.2.3 Global Estrogen Receptor Modulators Revenue Market Share by Type (2018-2029)
4.3 Global Estrogen Receptor Modulators Price by Type (2018-2029)
5 Segment by Application
5.1 Global Estrogen Receptor Modulators Sales by Application (2018-2029)
5.1.1 Global Estrogen Receptor Modulators Sales by Application (2018-2024)
5.1.2 Global Estrogen Receptor Modulators Sales by Application (2024-2029)
5.1.3 Global Estrogen Receptor Modulators Sales Market Share by Application (2018-2029)
5.2 Global Estrogen Receptor Modulators Revenue by Application (2018-2029)
5.2.1 Global Estrogen Receptor Modulators Revenue by Application (2018-2024)
5.2.2 Global Estrogen Receptor Modulators Revenue by Application (2024-2029)
5.2.3 Global Estrogen Receptor Modulators Revenue Market Share by Application (2018-2029)
5.3 Global Estrogen Receptor Modulators Price by Application (2018-2029)
6 Key Companies Profiled
6.1 F. Hoffmann-La Roche Ltd
6.1.1 F. Hoffmann-La Roche Ltd Corporation Information
6.1.2 F. Hoffmann-La Roche Ltd Description and Business Overview
6.1.3 F. Hoffmann-La Roche Ltd Estrogen Receptor Modulators Sales, Revenue and Gross Margin (2018-2024)
6.1.4 F. Hoffmann-La Roche Ltd Estrogen Receptor Modulators Product Portfolio
6.1.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
6.2 Mylan NV
6.2.1 Mylan NV Corporation Information
6.2.2 Mylan NV Description and Business Overview
6.2.3 Mylan NV Estrogen Receptor Modulators Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Mylan NV Estrogen Receptor Modulators Product Portfolio
6.2.5 Mylan NV Recent Developments/Updates
6.3 Teva Pharmaceutical Industries Ltd
6.3.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.3.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.3.3 Teva Pharmaceutical Industries Ltd Estrogen Receptor Modulators Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Teva Pharmaceutical Industries Ltd Estrogen Receptor Modulators Product Portfolio
6.3.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Corporation Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Estrogen Receptor Modulators Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Sanofi Estrogen Receptor Modulators Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Pfizer Inc
6.5.1 Pfizer Inc Corporation Information
6.5.2 Pfizer Inc Description and Business Overview
6.5.3 Pfizer Inc Estrogen Receptor Modulators Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Pfizer Inc Estrogen Receptor Modulators Product Portfolio
6.5.5 Pfizer Inc Recent Developments/Updates
6.6 GSK plc
6.6.1 GSK plc Corporation Information
6.6.2 GSK plc Description and Business Overview
6.6.3 GSK plc Estrogen Receptor Modulators Sales, Revenue and Gross Margin (2018-2024)
6.6.4 GSK plc Estrogen Receptor Modulators Product Portfolio
6.6.5 GSK plc Recent Developments/Updates
6.7 Novartis AG
6.6.1 Novartis AG Corporation Information
6.6.2 Novartis AG Description and Business Overview
6.6.3 Novartis AG Estrogen Receptor Modulators Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Novartis AG Estrogen Receptor Modulators Product Portfolio
6.7.5 Novartis AG Recent Developments/Updates
6.8 Bayer AG
6.8.1 Bayer AG Corporation Information
6.8.2 Bayer AG Description and Business Overview
6.8.3 Bayer AG Estrogen Receptor Modulators Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Bayer AG Estrogen Receptor Modulators Product Portfolio
6.8.5 Bayer AG Recent Developments/Updates
6.9 Lilly
6.9.1 Lilly Corporation Information
6.9.2 Lilly Description and Business Overview
6.9.3 Lilly Estrogen Receptor Modulators Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Lilly Estrogen Receptor Modulators Product Portfolio
6.9.5 Lilly Recent Developments/Updates
6.10 Merck & Co., Inc
6.10.1 Merck & Co., Inc Corporation Information
6.10.2 Merck & Co., Inc Description and Business Overview
6.10.3 Merck & Co., Inc Estrogen Receptor Modulators Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Merck & Co., Inc Estrogen Receptor Modulators Product Portfolio
6.10.5 Merck & Co., Inc Recent Developments/Updates
6.11 Sun Pharmaceutical Industries Ltd
6.11.1 Sun Pharmaceutical Industries Ltd Corporation Information
6.11.2 Sun Pharmaceutical Industries Ltd Estrogen Receptor Modulators Description and Business Overview
6.11.3 Sun Pharmaceutical Industries Ltd Estrogen Receptor Modulators Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Sun Pharmaceutical Industries Ltd Estrogen Receptor Modulators Product Portfolio
6.11.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
6.12 Aurobindo Pharma
6.12.1 Aurobindo Pharma Corporation Information
6.12.2 Aurobindo Pharma Estrogen Receptor Modulators Description and Business Overview
6.12.3 Aurobindo Pharma Estrogen Receptor Modulators Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Aurobindo Pharma Estrogen Receptor Modulators Product Portfolio
6.12.5 Aurobindo Pharma Recent Developments/Updates
6.13 Alkem Labs Ltd
6.13.1 Alkem Labs Ltd Corporation Information
6.13.2 Alkem Labs Ltd Estrogen Receptor Modulators Description and Business Overview
6.13.3 Alkem Labs Ltd Estrogen Receptor Modulators Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Alkem Labs Ltd Estrogen Receptor Modulators Product Portfolio
6.13.5 Alkem Labs Ltd Recent Developments/Updates
6.14 Apotex Inc
6.14.1 Apotex Inc Corporation Information
6.14.2 Apotex Inc Estrogen Receptor Modulators Description and Business Overview
6.14.3 Apotex Inc Estrogen Receptor Modulators Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Apotex Inc Estrogen Receptor Modulators Product Portfolio
6.14.5 Apotex Inc Recent Developments/Updates
6.15 Kyowa Kirin Co., Ltd
6.15.1 Kyowa Kirin Co., Ltd Corporation Information
6.15.2 Kyowa Kirin Co., Ltd Estrogen Receptor Modulators Description and Business Overview
6.15.3 Kyowa Kirin Co., Ltd Estrogen Receptor Modulators Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Kyowa Kirin Co., Ltd Estrogen Receptor Modulators Product Portfolio
6.15.5 Kyowa Kirin Co., Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Estrogen Receptor Modulators Industry Chain Analysis
7.2 Estrogen Receptor Modulators Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Estrogen Receptor Modulators Production Mode & Process
7.4 Estrogen Receptor Modulators Sales and Marketing
7.4.1 Estrogen Receptor Modulators Sales Channels
7.4.2 Estrogen Receptor Modulators Distributors
7.5 Estrogen Receptor Modulators Customers
8 Estrogen Receptor Modulators Market Dynamics
8.1 Estrogen Receptor Modulators Industry Trends
8.2 Estrogen Receptor Modulators Market Drivers
8.3 Estrogen Receptor Modulators Market Challenges
8.4 Estrogen Receptor Modulators Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Estrogen Receptor Modulators Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Estrogen Receptor Modulators Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Estrogen Receptor Modulators Market Competitive Situation by Manufacturers in 2022
Table 4. Global Estrogen Receptor Modulators Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Estrogen Receptor Modulators Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Estrogen Receptor Modulators Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Estrogen Receptor Modulators Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Estrogen Receptor Modulators Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Estrogen Receptor Modulators, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Estrogen Receptor Modulators, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Estrogen Receptor Modulators, Product Type & Application
Table 12. Global Key Manufacturers of Estrogen Receptor Modulators, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Estrogen Receptor Modulators by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Estrogen Receptor Modulators as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Estrogen Receptor Modulators Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Estrogen Receptor Modulators Sales by Region (2018-2024) & (K Units)
Table 18. Global Estrogen Receptor Modulators Sales Market Share by Region (2018-2024)
Table 19. Global Estrogen Receptor Modulators Sales by Region (2024-2029) & (K Units)
Table 20. Global Estrogen Receptor Modulators Sales Market Share by Region (2024-2029)
Table 21. Global Estrogen Receptor Modulators Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Estrogen Receptor Modulators Revenue Market Share by Region (2018-2024)
Table 23. Global Estrogen Receptor Modulators Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Estrogen Receptor Modulators Revenue Market Share by Region (2024-2029)
Table 25. North America Estrogen Receptor Modulators Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Estrogen Receptor Modulators Sales by Country (2018-2024) & (K Units)
Table 27. North America Estrogen Receptor Modulators Sales by Country (2024-2029) & (K Units)
Table 28. North America Estrogen Receptor Modulators Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Estrogen Receptor Modulators Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Estrogen Receptor Modulators Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Estrogen Receptor Modulators Sales by Country (2018-2024) & (K Units)
Table 32. Europe Estrogen Receptor Modulators Sales by Country (2024-2029) & (K Units)
Table 33. Europe Estrogen Receptor Modulators Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Estrogen Receptor Modulators Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Estrogen Receptor Modulators Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Estrogen Receptor Modulators Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Estrogen Receptor Modulators Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Estrogen Receptor Modulators Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Estrogen Receptor Modulators Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Estrogen Receptor Modulators Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Estrogen Receptor Modulators Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Estrogen Receptor Modulators Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Estrogen Receptor Modulators Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Estrogen Receptor Modulators Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Estrogen Receptor Modulators Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Estrogen Receptor Modulators Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Estrogen Receptor Modulators Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Estrogen Receptor Modulators Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Estrogen Receptor Modulators Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Estrogen Receptor Modulators Sales (K Units) by Type (2018-2024)
Table 51. Global Estrogen Receptor Modulators Sales (K Units) by Type (2024-2029)
Table 52. Global Estrogen Receptor Modulators Sales Market Share by Type (2018-2024)
Table 53. Global Estrogen Receptor Modulators Sales Market Share by Type (2024-2029)
Table 54. Global Estrogen Receptor Modulators Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Estrogen Receptor Modulators Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Estrogen Receptor Modulators Revenue Market Share by Type (2018-2024)
Table 57. Global Estrogen Receptor Modulators Revenue Market Share by Type (2024-2029)
Table 58. Global Estrogen Receptor Modulators Price (US$/Unit) by Type (2018-2024)
Table 59. Global Estrogen Receptor Modulators Price (US$/Unit) by Type (2024-2029)
Table 60. Global Estrogen Receptor Modulators Sales (K Units) by Application (2018-2024)
Table 61. Global Estrogen Receptor Modulators Sales (K Units) by Application (2024-2029)
Table 62. Global Estrogen Receptor Modulators Sales Market Share by Application (2018-2024)
Table 63. Global Estrogen Receptor Modulators Sales Market Share by Application (2024-2029)
Table 64. Global Estrogen Receptor Modulators Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Estrogen Receptor Modulators Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Estrogen Receptor Modulators Revenue Market Share by Application (2018-2024)
Table 67. Global Estrogen Receptor Modulators Revenue Market Share by Application (2024-2029)
Table 68. Global Estrogen Receptor Modulators Price (US$/Unit) by Application (2018-2024)
Table 69. Global Estrogen Receptor Modulators Price (US$/Unit) by Application (2024-2029)
Table 70. F. Hoffmann-La Roche Ltd Corporation Information
Table 71. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 72. F. Hoffmann-La Roche Ltd Estrogen Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. F. Hoffmann-La Roche Ltd Estrogen Receptor Modulators Product
Table 74. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 75. Mylan NV Corporation Information
Table 76. Mylan NV Description and Business Overview
Table 77. Mylan NV Estrogen Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Mylan NV Estrogen Receptor Modulators Product
Table 79. Mylan NV Recent Developments/Updates
Table 80. Teva Pharmaceutical Industries Ltd Corporation Information
Table 81. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 82. Teva Pharmaceutical Industries Ltd Estrogen Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Teva Pharmaceutical Industries Ltd Estrogen Receptor Modulators Product
Table 84. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 85. Sanofi Corporation Information
Table 86. Sanofi Description and Business Overview
Table 87. Sanofi Estrogen Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Sanofi Estrogen Receptor Modulators Product
Table 89. Sanofi Recent Developments/Updates
Table 90. Pfizer Inc Corporation Information
Table 91. Pfizer Inc Description and Business Overview
Table 92. Pfizer Inc Estrogen Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Pfizer Inc Estrogen Receptor Modulators Product
Table 94. Pfizer Inc Recent Developments/Updates
Table 95. GSK plc Corporation Information
Table 96. GSK plc Description and Business Overview
Table 97. GSK plc Estrogen Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. GSK plc Estrogen Receptor Modulators Product
Table 99. GSK plc Recent Developments/Updates
Table 100. Novartis AG Corporation Information
Table 101. Novartis AG Description and Business Overview
Table 102. Novartis AG Estrogen Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Novartis AG Estrogen Receptor Modulators Product
Table 104. Novartis AG Recent Developments/Updates
Table 105. Bayer AG Corporation Information
Table 106. Bayer AG Description and Business Overview
Table 107. Bayer AG Estrogen Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Bayer AG Estrogen Receptor Modulators Product
Table 109. Bayer AG Recent Developments/Updates
Table 110. Lilly Corporation Information
Table 111. Lilly Description and Business Overview
Table 112. Lilly Estrogen Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Lilly Estrogen Receptor Modulators Product
Table 114. Lilly Recent Developments/Updates
Table 115. Merck & Co., Inc Corporation Information
Table 116. Merck & Co., Inc Description and Business Overview
Table 117. Merck & Co., Inc Estrogen Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Merck & Co., Inc Estrogen Receptor Modulators Product
Table 119. Merck & Co., Inc Recent Developments/Updates
Table 120. Sun Pharmaceutical Industries Ltd Corporation Information
Table 121. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 122. Sun Pharmaceutical Industries Ltd Estrogen Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Sun Pharmaceutical Industries Ltd Estrogen Receptor Modulators Product
Table 124. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 125. Aurobindo Pharma Corporation Information
Table 126. Aurobindo Pharma Description and Business Overview
Table 127. Aurobindo Pharma Estrogen Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Aurobindo Pharma Estrogen Receptor Modulators Product
Table 129. Aurobindo Pharma Recent Developments/Updates
Table 130. Alkem Labs Ltd Corporation Information
Table 131. Alkem Labs Ltd Description and Business Overview
Table 132. Alkem Labs Ltd Estrogen Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Alkem Labs Ltd Estrogen Receptor Modulators Product
Table 134. Alkem Labs Ltd Recent Developments/Updates
Table 135. Apotex Inc Corporation Information
Table 136. Apotex Inc Description and Business Overview
Table 137. Apotex Inc Estrogen Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Apotex Inc Estrogen Receptor Modulators Product
Table 139. Apotex Inc Recent Developments/Updates
Table 140. Kyowa Kirin Co., Ltd Corporation Information
Table 141. Kyowa Kirin Co., Ltd Description and Business Overview
Table 142. Kyowa Kirin Co., Ltd Estrogen Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Kyowa Kirin Co., Ltd Estrogen Receptor Modulators Product
Table 144. Kyowa Kirin Co., Ltd Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Estrogen Receptor Modulators Distributors List
Table 148. Estrogen Receptor Modulators Customers List
Table 149. Estrogen Receptor Modulators Market Trends
Table 150. Estrogen Receptor Modulators Market Drivers
Table 151. Estrogen Receptor Modulators Market Challenges
Table 152. Estrogen Receptor Modulators Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Estrogen Receptor Modulators
Figure 2. Global Estrogen Receptor Modulators Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Estrogen Receptor Modulators Market Share by Type in 2022 & 2029
Figure 4. Breast Cancer Product Picture
Figure 5. Vaginitis Product Picture
Figure 6. Osteoporosis Product Picture
Figure 7. Other Product Picture
Figure 8. Global Estrogen Receptor Modulators Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Estrogen Receptor Modulators Market Share by Application in 2022 & 2029
Figure 10. Breast Cancer
Figure 11. Postmenopausal Osteoporosis
Figure 12. Other
Figure 13. Global Estrogen Receptor Modulators Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Estrogen Receptor Modulators Market Size (2018-2029) & (US$ Million)
Figure 15. Global Estrogen Receptor Modulators Sales (2018-2029) & (K Units)
Figure 16. Global Estrogen Receptor Modulators Average Price (US$/Unit) & (2018-2029)
Figure 17. Estrogen Receptor Modulators Report Years Considered
Figure 18. Estrogen Receptor Modulators Sales Share by Manufacturers in 2022
Figure 19. Global Estrogen Receptor Modulators Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Estrogen Receptor Modulators Players: Market Share by Revenue in 2022
Figure 21. Estrogen Receptor Modulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Estrogen Receptor Modulators Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Estrogen Receptor Modulators Sales Market Share by Country (2018-2029)
Figure 24. North America Estrogen Receptor Modulators Revenue Market Share by Country (2018-2029)
Figure 25. United States Estrogen Receptor Modulators Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Estrogen Receptor Modulators Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Estrogen Receptor Modulators Sales Market Share by Country (2018-2029)
Figure 28. Europe Estrogen Receptor Modulators Revenue Market Share by Country (2018-2029)
Figure 29. Germany Estrogen Receptor Modulators Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Estrogen Receptor Modulators Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Estrogen Receptor Modulators Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Estrogen Receptor Modulators Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Estrogen Receptor Modulators Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Estrogen Receptor Modulators Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Estrogen Receptor Modulators Revenue Market Share by Region (2018-2029)
Figure 36. China Estrogen Receptor Modulators Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Estrogen Receptor Modulators Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Estrogen Receptor Modulators Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Estrogen Receptor Modulators Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Estrogen Receptor Modulators Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Estrogen Receptor Modulators Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Estrogen Receptor Modulators Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Estrogen Receptor Modulators Sales Market Share by Country (2018-2029)
Figure 44. Latin America Estrogen Receptor Modulators Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Estrogen Receptor Modulators Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Estrogen Receptor Modulators Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Estrogen Receptor Modulators Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Estrogen Receptor Modulators Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Estrogen Receptor Modulators Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Estrogen Receptor Modulators Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Estrogen Receptor Modulators Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Estrogen Receptor Modulators Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Estrogen Receptor Modulators by Type (2018-2029)
Figure 54. Global Revenue Market Share of Estrogen Receptor Modulators by Type (2018-2029)
Figure 55. Global Estrogen Receptor Modulators Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Estrogen Receptor Modulators by Application (2018-2029)
Figure 57. Global Revenue Market Share of Estrogen Receptor Modulators by Application (2018-2029)
Figure 58. Global Estrogen Receptor Modulators Price (US$/Unit) by Application (2018-2029)
Figure 59. Estrogen Receptor Modulators Value Chain
Figure 60. Estrogen Receptor Modulators Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed